Company intelligence / Profile preview

건강중심주의

충청북도, 대한민국nongshim.com ↗

Ownership: Private
Development stage: Preclinical

Overview

건강중심주의는 미토콘드리아 기능 강화와 NAD+ 증가 기술을 바탕으로 한 항노화 및 건강기능식품 소재 개발에 특화된 바이오기업이다. 대표 원료인 '단삼주정추출분말(SAGX)'은 서울성모병원과 고려대 구로병원에서 진행된 인체적용시험을 통해 전립선 증상 완화 효과와 안전성을 입증받아 식약처 개별인정형 원료 허가를 획득했다. 주요 파이프라인은 에너지 대사 최적화를 위한 NAD+/세놀리틱 기반 신소재 개발이며, 큐롬바이오사이언스의 기술 협력과 디오니헬스케어의 유통망을 활용해 시장 진입을 가속하고 있다.

Therapeutic areas: Metabolic DisordersMen's Health
Modalities: 기능성 식품소재 (Functional food ingredients)항노화 소재 (Anti-aging ingredients)NAD+ 증가 기술 기반 제품세놀리틱(Senolytic) 기반 제품단삼주정추출분말(Salvia miltiorrhiza extract, SAGX)
Industry: Food & Nutrition

Drug pipeline

1 asset

cryptotanshinone

Pre-clinical

Indications: Aging, Prostate health

Partnerships

큐롬바이오사이언스(NAD+ 촉진제 기술 협력)디오니헬스케어(유통 파트너십)

Beyond the preview

Go deeper on 건강중심주의.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 건강중심주의.

Explore the full profile